PDF
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
Organization: Public Health Agency of Canada (PHAC)Published: 2023
Image
The primary objective of this Interim Guidance is to review evidence on the safety and immunogenicity of PNEU-C-15 in the pediatric age group and to develop interim recommendations on its interchangeability with PNEU-C-13 for use in routine pediatric schedules as well as for children at high risk of IPD.
Resource Group:
Implementation Tool
Product Type: Guide
Program Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations
Children
Product Type: Guide
Category:
Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Preventable Diseases,Communicable Diseases,Pneumococcal Disease,Specific Populations,Children Program Planning and DeliveryProgram Delivery and Evaluation
Clinics
Vaccine Preventable Diseases
Communicable Diseases
Pneumococcal Disease
Specific Populations
Children
Region:
National
Language:
English
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.